naproxen has been researched along with d-alpha tocopherol in 11 studies
| Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (d-alpha tocopherol) | Trials (d-alpha tocopherol) | Recent Studies (post-2010) (d-alpha tocopherol) |
|---|---|---|---|---|---|
| 4,551 | 1,057 | 1,429 | 32,198 | 2,903 | 7,258 |
| Protein | Taxonomy | naproxen (IC50) | d-alpha tocopherol (IC50) |
|---|---|---|---|
| Glutathione S-transferase P | Homo sapiens (human) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| David, KC; Delgado, P; Graff, G; Haggard, KS; Hellberg, MR; Kessler, TL; Namil, A; Nixon, JC | 1 |
| DeWitt, DL; Mattson, WG; Nair, MG; Ramsewak, RS; Zasada, J | 1 |
| Strassburg, CP; Tukey, RH | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fritz, ME; Green, MD; Mayambala, CS; Odle, BM; Offenbacher, S; Sena, FJ; Smith, MA; van Dyke, TE; Yeh, KC | 1 |
| Awazu, S; Horie, T; Yokoyama, H | 1 |
| Alpar, R; Hincal, AA; Kaş, HS; Nasirideen, S; Oner, F | 1 |
| Augustijns, P; Froyen, L; Humbeeck, JV; Martens, JA; Van den Mooter, G; Van Eerdenbrugh, B; Vermant, J | 1 |
| George, M; Ghosh, I | 1 |
| Degenhardt, M; Kyeremateng, SO; Lehmkemper, K; Sadowski, G | 1 |
2 review(s) available for naproxen and d-alpha tocopherol
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for naproxen and d-alpha tocopherol
| Article | Year |
|---|---|
Novel esters and amides of nonsteroidal antiinflammatory carboxylic acids as antioxidants and antiproliferative agents.
Topics: Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Carboxylic Acids; Cattle; Cell Division; Cells, Cultured; Child, Preschool; DNA; Endothelium, Vascular; Esters; Female; Humans; Lipid Peroxidation; Magnetic Resonance Spectroscopy; Molecular Structure | 1999 |
Phenolic glycosides from Dirca palustris.
Topics: Animals; Antioxidants; Chromatography, Liquid; Chromatography, Thin Layer; Circular Dichroism; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; In Vitro Techniques; Isoenzymes; Liposomes; Magnetic Resonance Spectroscopy; Male; North America; Phenols; Plants, Medicinal; Prostaglandin-Endoperoxide Synthases; Seminal Vesicles; Sheep; Spectrometry, Mass, Fast Atom Bombardment | 1999 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibition of human periodontal prostaglandin E2 synthesis with selected agents.
Topics: Arachidonic Acid; Arachidonic Acids; Chromatography, High Pressure Liquid; Cyclooxygenase Inhibitors; Dinoprostone; Eicosapentaenoic Acid; Flurbiprofen; Humans; Ibuprofen; Ketoprofen; Meclofenamic Acid; Naproxen; Periodontitis; Periodontium; Vitamin E | 1990 |
Lipid peroxidation and chemiluminescence during naproxen metabolism in rat liver microsomes.
Topics: Animals; Antimutagenic Agents; Antioxidants; Ascorbic Acid; Cobalt; Electrophoresis, Polyacrylamide Gel; Ferrous Compounds; Histidine; Lipid Peroxidation; Luminescent Measurements; Magnesium Chloride; Male; Microsomes, Liver; Molecular Weight; NADP; Naproxen; Piperonyl Butoxide; Proadifen; Rats; Rats, Wistar; Reactive Oxygen Species; Thiobarbituric Acid Reactive Substances; Vitamin E | 1994 |
Naproxen incorporated lipid emulsions. I. Formulation and stability studies.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Drug Stability; Excipients; Fat Emulsions, Intravenous; Humans; Hydrogen-Ion Concentration; Naproxen; Parenteral Nutrition; Particle Size; Phosphatidylcholines; Soybean Oil; Temperature; Viscosity; Vitamin E | 1998 |
Solubility increases associated with crystalline drug nanoparticles: methodologies and significance.
Topics: Acetamides; Acetophenones; Chemistry, Pharmaceutical; Crystallization; Drug Stability; Excipients; Itraconazole; Light; Micelles; Nanoparticles; Naproxen; Nephelometry and Turbidimetry; Particle Size; Phenytoin; Polyethylene Glycols; Scattering, Radiation; Solubility; Suspensions; Vitamin E | 2010 |
Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology.
Topics: 1-Octanol; Dioctyl Sulfosuccinic Acid; Drug Compounding; Drug Stability; Hypromellose Derivatives; Methylcellulose; Molecular Weight; Nanoparticles; Naproxen; Pharmaceutical Preparations; Poloxamer; Polyethylene Glycols; Sodium Dodecyl Sulfate; Solubility; Surface-Active Agents; Suspensions; Transition Temperature; Vitamin E; Water | 2013 |
Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.
Topics: Acetaminophen; Administration, Oral; alpha-Tocopherol; Chemistry, Pharmaceutical; Excipients; Humans; Models, Molecular; Molecular Weight; Naproxen; Phase Transition; Polyethylene Glycols; Pyrrolidines; Solubility; Thermodynamics; Transition Temperature; Vinyl Compounds | 2018 |